Fireside Chat: New Treatment Options for High-Risk Prostate Cancer Webinar Recap: BRCA Testing, PARP Inhibitors, and the EvoPAR-Prostate02 Clinical Trial This webinar focused on men with high-risk prostate cancer and a clinical trial called EvoPAR-Prostate02. The discussion was led by Dr. Keith Crawford with guest expert Dr. Rana McKay, a genitourinary medical oncologist who treats […]
PHEN Clinical Trials Learning Session Presented in Collaboration with Pfizer The Prostate Health Education Network (PHEN), in collaboration with Pfizer, recently hosted a Clinical Trials Learning Session focused on emerging research in metastatic castration-resistant prostate cancer (mCRPC). The program highlighted three coordinated Phase 3 clinical studies evaluating an investigational twice-daily oral EZH2 inhibitor in combination […]
